[1] Kubal C, Mangus R, Fridell J, et al. Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation. Transplantation, 2016, 100(8): 1699-1704.
[2] Reiling J, Bridle KR, Gijbels M, et al. Low-dose lipopolysaccharide causes biliary injury by blood biliary barrier impairment in a rat hepatic ischemia/reperfusion model. Liver Transpl, 2017, 23(2): 194-206.
[3] Lattanzi B, Ott P, Rasmussen A, et al. Ischemic damage represents the main risk factor for biliary stricture after liver transplantation: A follow-up study in a danish population. In Vivo, 2018, 32(6): 1623-1628.
[4] Fonseca F, Kulkarni B, Hastak M, et al. An overview of liver transplant pathology: data from a tertiary referral centre in western india. Ann Hepatol, 2018, 17(3): 426-436.
[5] 李伟, 王瑞星, 韩久付, 等. 腹部CT和EUS检查慢性胰腺炎患者表现特点及其诊断价值分析. 实用肝脏病杂志, 2018, 21(5): 785-788.
[6] Hong SY, Hu XG, Lee HY, et al. Longterm analysis of biliary complications after duct-to-duct biliary reconstruction in living donor liver transplantations. Liver Transpl, 2018, 24(8): 1050-1061.
[7] Ruiz de Azúa-López Z, Naranjo-Izurieta JR, Lameirao J, et al. Cold ischemia time as a factor in post-transplantation complications for orthotopic hepatic transplantation. Transplant Proc, 2018, 50(2): 637-639.
[8] 傅斌生, 易述红, 唐晖, 等.公民逝世后器官捐献肝移植术后胆道并发症供者相关危险因素分析.中华肝脏外科手术学电子杂志, 2016, 5(4): 235-239.
[9] van Rijn R, van Leeuwen OB, Matton APM, et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers. Liver Transpl, 2018, 24(5): 655-664.
[10] 丁蕾, 张振, 刘福全. 实时超声弹性成像技术对原位肝移植患者术后缺血型胆道病变临床评估价值分析. 实用肝脏病杂志, 2018, 21(6): 963-966.
[11] Zhang J, Ren FG, Liu P, et al. Characteristics of fecal microbial communities in patients with non-anastomotic biliary strictures after liver transplantation. World J Gastroenterol, 2017, 23(46): 8217-8226.
[12] Montalti R, Benedetti Cacciaguerra A, Nicolini D, et al. Impact of aberrant left hepatic artery ligation on the outcome of liver transplantation. Liver Transpl, 2018, 24(2): 204-213.
[13] Patrono D, Lavezzo B, Molinaro L, et al. Hypothermic oxygenated machine perfusion for liver transplantation: An initial experience. Exp Clin Transplant, 2018, 16(2): 172-176.
[14] 王正昕,钦伦秀. 肝移植术后并发症的防治现状及进展. 中国普外基础与临床杂志,2018,25(09):1025-1030.
[15] 林诗彬, 郑恩海, 杨克丰, 等. 彩色多普勒超声检查对乙型肝炎肝硬化患者食管静脉曲张预测价值分析. 实用肝脏病杂志, 2019,22(3): 409-412.
[16] Baker TB, Zimmerman MA, Goodrich NP, et al. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver Transpl, 2017, 23(12): 1519-1530.
[17] Jiang T, Li C, Duan B, et al. Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience. Ann Hepatol, 2016, 15(1): 41-46.
[18] Fujiki M, Hashimoto K, Palaios E, et al. Probability, management, and long-term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients. Surgery, 2017, 162(5): 1101-1111.
[19] Junger HH, Schlitt HJ, Geissler EK, et al. Bile duct regeneration and immune response by passenger lymphocytes signals biliary recovery versus complications after liver transplantation. Liver Transpl, 2017, 23(11): 1422-1432.
[20] Bohorquez H, Seal JB, Cohen AJ, et al. Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy. Am J Transplant, 2017, 17(8): 2155-2164.
[21] Goldberg DS, Karp SJ, McCauley ME, et al. Interpreting outcomes in dcdd liver transplantation: first report of the multicenter idol consortium. Transplantation, 2017, 101(5): 1067-1073.
[22] Prieto M, Valdivieso A, Gastaca M, et al. Hepaticojejunostomy in orthotopic liver transplant: a retrospective case control study. Transplant Proc, 2019, 51(1): 58-61.
[23] 赵宇, 祝瑜, 张代忠. 人脐带间充质干细胞肝内移植联合苦参素治疗失代偿期乙型肝炎肝硬化患者疗效与转归分析. 实用肝脏病杂志, 2018, 21(3): 360-363.
[24] Hessheimer AJ, Vendrell M, Muoz J, et al. Heparin but not tissue plasminogen activator improves outcomes in donation after circulatory death liver transplantation in a porcine model. Liver Transpl, 2018, 24(5): 665-676.
a) Dominguez Bastante M, Molina Raya A, Vilchez Rabelo A, et al. Analysis of ischemic cholangiopathy after treatment of arterial thrombosis in liver transplantation in our series. Transplant Proc, 2018, 50(2): 628-630. |